Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Capital goods lead among gainers
Thu, 14 Nov 01:30 pm

Indian markets have shed some gains in last two hours of trade, but still continue to trade in positive territory. Barring stocks from pharma sector, all the sectoral indices are trading in green. Among the gainers, stocks from capital goods and auto sector are witnessing maximum buying interest.

BSE-Sensex is up by 264 points and NSE-Nifty is trading up by 78 points. While BSE Mid Cap is trading up by 0.96%, BSE Small Cap index is trading up by 1.04%. The rupee is trading at 63.17 to the US dollar.

Indian pharma stocks are trading in green with Natco pharma and Dishman pharma being the leading gainers. Cipla has declared its September quarter results. Net sales increased by 13.6% YoY for the 2QFY14. The growth was led by both domestic and international segments. Domestic business grew by 11.6% YoY, while international business grew by 15.2% YoY. During the quarter, the company also consolidated the acquired business of Cipla Medpro. On the operating front, EBITDA declined by 19.6% YoY, leading to decline in the margins by 9.1%. The impact was largely due to sales of Escitalopram under 180-days in 2QFY13 and higher contribution from low margins ARV (Antiretrovirals) during the quarter. The bottom line too was impacted due to absence of Escitalopram for the current quarter. PAT was down 27% YoY for the said period. Cipla is currently trading down by 1.09%.

Majority of the Automobile stocks are trading in the green with TVS motors and Tata Motors being the major gainers. As per a leading financial daily, Hero Motorcorp is looking to launch two-wheelers in United States and Canada. Reportedly, Hero has appointed its American technology partner Erik Buell Racing as the exclusive distributor. Hero Motorcorp intends to eventually set up manufacturing and assembly plants in the North America over a period of time. Further, a "soft launch" of Hero two-wheelers was held during the month of Oct 2013 at the inaugural American International Motorcycle Expo (AIMExpo). The event took place in Orlando, Florida, where Hero displayed some of its popular brands such as Hunk, ZMR, the updated HF Deluxe Eco, Splendor Pro and the Pleasure scooter. The other details with respect to pricing etc are yet to be determined. Hero Motorcorp is currently trading up by 2.27%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Capital goods lead among gainers". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.